Comparison between Aurobindo Pharma Buyback 2026 and Rolex Rings Buyback 2026.
Aurobindo Pharma Buyback 2026 is a Tender Offer buyback proposed to list at BSE, NSE while Rolex Rings Buyback 2026 is a Tender Offer proposed to list at BSE, NSE.
| Aurobindo Pharma Ltd | Rolex Rings Ltd. | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Logo | ![]() | ![]() | ||||||||||||||||||
| Type of Buyback | Tender Offer | Tender Offer | ||||||||||||||||||
| Listing At | BSE, NSE | BSE, NSE | ||||||||||||||||||
| Face Value | ₹10 per share | ₹1 per share | ||||||||||||||||||
| Buyback Price | ₹1475 per share | ₹180 per share | ||||||||||||||||||
| Issue Size | 54,23,728 shares | 1,00,00,000 shares | ||||||||||||||||||
| Issue Size (Amount) | ₹800.00 Crores | ₹180.00 Crores | ||||||||||||||||||
| Buyback Ratio |
Note:
|
Note:
| ||||||||||||||||||
| Registrar | Kfin Technologies Ltd. | MUFG Intime India Pvt.Ltd. | ||||||||||||||||||
| Lead Managers | Axis Capital Ltd. | Equirus Capital Ltd. | ||||||||||||||||||
| Necessity of the buyback | The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
|
Aurobindo Pharma Buyback 2026 and Rolex Rings Buyback 2026 buyback timetable. The investors should have the company's shares in their demat accounts as of the record date. Aurobindo Pharma Buyback 2026 Buyback record date is Apr 17, 2026. Rolex Rings Buyback 2026 Buyback record date is Jul 03, 2026.
| Aurobindo Pharma Ltd | Rolex Rings Ltd. | |
|---|---|---|
| Record Date | Apr 17, 2026 | Jul 03, 2026 |
| Offer Open Date | Apr 23, 2026 | Jul 09, 2026 |
| Offer Closure Date | Apr 29, 2026 | Jul 15, 2026 |
| Last date for receipt of tender forms | Apr 29, 2026 | Jul 15, 2026 |
| Finalisation of buyback | May 07, 2026 | Jul 21, 2026 |
| Last Date for settlment of bids | May 07, 2026 | Jul 22, 2026 |
| Last Date for extinguishment of shares | May 18, 2026 | Jul 31, 2026 |
Comparison of Aurobindo Pharma Buyback 2026 and Rolex Rings Buyback 2026 financial data. The table below also includes a list of all relevant information like Stock Market Data, Compay Information, Lead Manager and Registrar.
| Aurobindo Pharma Ltd | Rolex Rings Ltd. | |||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financial | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)Rolex Rings Ltd.'s revenue increased by 1% and profit after tax (PAT) dropped by 19% between the financial year ending with March 31, 2026 and March 31, 2025.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Stock price at BSE | Stock price at BSE (in preceding 3 months)
| Stock price at BSE (in preceding 3 months)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Stock price at NSE | Stock price at NSE (in preceding 3 months)
| Stock price at NSE (in preceding 3 months)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||